Loading
Bird Parasitology and Diseases / Virology and Viral Diseases / Microbial Infections and Disease Research · Journal article
Frontiers in Immunology · September 8, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review synthesizing current understanding of Riemerella anatipestifer pathogenesis, immune evasion, and host-pathogen interactions. It identifies fragmented mechanistic insights and knowledge gaps but does not report original empirical findings or comparative efficacy data; it frames disease progression as shaped by both bacterial pathogenicity and dysregulated host immune responses, and highlights the need for durable, broadly protective intervention strategies.
Journal article. Riemerella anatipestifer infection in waterfowls, poultry, and wild bird species.
RA is recognized across waterfowls, poultry production systems, and wild bird species, showing expanding host range and adaptive potential Disease persistence is attributed to serotype diversity, limited cross-protective immunity, evolving antimicrobial resistance, and incomplete understanding of host-pathogen interactions Dysregulated inflammatory signaling and immune-mediated tissue damage contribute significantly to disease pathology alongside bacterial pathogenicity
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies that effective control requires understanding of both pathogen adaptation and host immune dysregulation; however, as a narrative synthesis without new empirical data or comparative intervention results, it does not immediately change clinical practice but highlights the need for integrated, broadly protective strategies.
This is a narrative review synthesizing fragmented mechanistic and immunological evidence on a pathogen; it raises questions about host-pathogen dynamics rather than reporting original empirical results or definitive answers.
This review identifies that effective control requires understanding of both pathogen adaptation and host immune dysregulation; however, as a narrative synthesis without new empirical data or comparative intervention results, it does not immediately change clinical practice but highlights the need for integrated, broadly protective strategies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Riemerella anatipestifer (RA) is an economically important avian pathogen that has historically caused significant disease in waterfowls but is increasingly recognized in various poultry production systems and wild bird species, highlighting its expanding host range and adaptive potential. Despite the availability of vaccines and antimicrobial interventions, RA remains a persistent challenge due to serotype diversity, limited cross-protective immunity, evolving antimicrobial resistance patterns, and an incomplete understanding of the host-pathogen interactions that govern disease outcome. Recent advances in genomics, molecular epidemiology, immunology and vaccinology have generated new insights into RA evolution, pathogenicity, host adaptation, and immune protection. However, these advances remain fragmented, hindering the translation of mechanistic discoveries into broadly effective control strategies. Emerging evidence further indicates that disease progression is shaped not only by bacterial pathogenicity but also by the magnitude and regulation of host immune responses, where dysregulated inflammatory signaling and immune-mediated tissue damage contribute significantly to pathology. This review synthesizes current understanding of the dynamic interplay between pathogen adaptation, immune evasion, host defense responses, and immunopathogenesis that collectively determines disease susceptibility, progression and protection. Finally, we evaluate current vaccine platforms and alternative control approaches, identify major knowledge gaps, and highlight future directions for the development of durable, broadly protective and sustainable intervention strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.